Return on Capital Employed Overview: Conformis
After pulling data from Benzinga Pro it seems like during Q2, Conformis (NASDAQ:CFMS) earned $30.89 million, a 437.8% increase from the preceding quarter. Conformis also posted a total of $56.35 million in sales, a 307.29% increase since Q1.
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system.
Identity Imprint, available in both cruciate retaining (CR) and posterior
Conformis Q2 Earnings Surpass Estimates On Higher Volumes And Royalties, License Revenue
Conformis Inc (NASDAQ:CFMS) Q2 revenues more than doubled to $56.3 million, beating the consensus of $33 million. The increase was…
Conformis Sees Q3 Sales $15.5M-$16.5M vs $17.21M Est.
Outlook
We expect our third quarter product revenue to improve sequentially from the second quarter and to be in the range of $15.5 million to $16.5 million.
Conformis Q2 EPS $0.21 Beats $0.04 Estimate, Sales $56.30M Beat $33.00M Estimate
Conformis (NASDAQ:CFMS) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.04 by 425 percent. This is a 800 percent increase over losses of $(0.03) per share from the same
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.